709673452 - Supply of Obiltoxaximab Treatment RFI
The Ministry of Defence (MOD) are considering a requirement to procure UK/EU Licensed Obiltoxaximab Treatment as soon as is technically possible. To inform this requirement, the MOD seek information in response to the following: a. Whether it is possible to supply a UK/EU Licensed Obiltoxaximab b. If there is a minimum order quantity c. What price breaks apply, if any. d. Evidence of UK/EU Licensing e. Is this product commercially available off-the-shelf (COTS) f. Indicative pricing g. Lead times In addition to con...
Buyer
Ministry of Defence
Value
Not provided
Published
2 Nov 2023
Closes
2 Nov 2023
Procurement details
Source
Contracts Finder
Region
United Kingdom
Procurement method
Not provided
Category
Goods
Contract starts
Not provided
Contract ends
Not provided
CPV classifications
33600000
Pharmaceutical products
Lots
Lot default 709673452 - Supply of Obiltoxaximab Treatment RFI
Value not provided
The Ministry of Defence (MOD) are considering a requirement to procure UK/EU Licensed Obiltoxaximab Treatment as soon as is technically possible. To inform this requirement, the MOD seek information in response to the following: a. Whether it is possible to supply a UK/EU Licensed Obiltoxaximab b. If there is a minimum order quantity c. What price breaks app...
Delivery: South West · United Kingdom, South West, United Kingdom
Documents
Unlock document linkEarly engagement notice on Contracts Finder
2 Nov 2023
Early engagement notice on Contracts Finder
Market engagement notice · Web page
Link to Defence Opportunity
Not provided
Link to Defence Opportunity
Document
Contains public sector information licensed under the Open Government Licence v3.0.